BGNE – beigene, ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
BeiGene, Ltd. (NASDAQ: BGNE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at TD Cowen from $254.00 to $260.00. They now have a "buy" rating on the stock.
Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight [Yahoo! Finance]
BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
Form 8-K BeiGene, Ltd. For: Nov 14
Form 10-Q BeiGene, Ltd. For: Sep 30
Form 8-K BeiGene, Ltd. For: Nov 12
Form 8-K BeiGene, Ltd. For: Oct 25
Form 4 BeiGene, Ltd. For: Oct 08 Filed by: OYLER JOHN
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.